AstraZeneca May Have Gotten Themselves Into Some Hot Water
AstraZeneca PLC (AZN) was down sharply in trading today on high volume. The apparent reason for the decline is increasing pushes for regulatory action to be taken to address drug prices. Congressional lawmakers introduced a bill to lower drug prices on Friday, and Rep. Cummings opened an investigation into drug prices today. Here’s a recap.
Read Article